Hester Biosciences Ltd

NSE: HESTERBIO · BSE: 524669 · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹2,157.00
Market cap: ₹1,835 Cr
Revenue (annual): ₹332.6 Cr
Net profit (annual): ₹55.64 Cr
P/E (TTM): 13.5×Sector 47.4×
Promoter holding: 53.73%+0.00% QoQ
FII holding: 0.31%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 4 Annual General Meeting 4 Promoter Reclassification 3 Other Announcement 3 Financial Results 2 Debt & Borrowing 2 Board Meeting Date 2 Results Update 1 Merger & Restructuring 1 Management Change 1 Credit Rating 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

20 May 2026 16:01 IST BSE

Debt & Borrowing

Hester Biosciences Debt & Borrowing: ₹48 Cr

Hester Biosciences modified its corporate guarantee for subsidiary Hester Africa's loan, now reduced to USD 5 million. The amendment improves subsidiary liquidity and debt servicing positions.

Value: ₹48.00 Cr

Read the filing ↗

3 Apr 2026 15:12 IST BSE

Debt & Borrowing

Hester Biosciences Debt & Borrowing: ₹12.78 Cr

Hester Biosciences Limited confirmed it is not classified as a 'Large Corporate' under SEBI's framework for the financial year. As of March 31, 2026, the company reported outstanding long-term borrowings of ₹12.78 Crore and maintains a 'BBB+: Stable' credit rating from CARE Ratings.

Value: ₹12.78 Cr

Read the filing ↗